Dixon Mitchell Investment Counsel Inc. Gsk PLC Transaction History

Dixon Mitchell Investment Counsel Inc.

$2.2 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2015 Jan 17, 2024	SELL	N/A	-40,083 Closed	0 $0
Q2 2015 Jan 17, 2024	SELL	N/A	-757 Reduced 1.85%	40,083 $1.67 Billion
Q1 2015 Jan 17, 2024	SELL	N/A	-4,640 Reduced 10.2%	40,840 $1.88 Billion
Q3 2014 Jan 17, 2024	SELL	N/A	-1,015 Reduced 2.18%	45,480 $2.09 Billion
Q2 2014 Jan 17, 2024	SELL	N/A	-620 Reduced 1.32%	46,495 $2.49 Billion
Q1 2014 Jan 17, 2024	BUY	N/A	300 Added 0.64%	47,115 $2.52 Billion
Q4 2013 Jan 17, 2024	BUY	N/A	1,170 Added 2.56%	46,815 $2.5 Billion
Q3 2013 Jan 17, 2024	SELL	N/A	-1,630 Reduced 3.45%	45,645 $2.29 Billion
Q2 2013 Jan 17, 2024	BUY	N/A	2,880 Added 6.49%	47,275 $2.36 Billion
Q1 2013 Jan 17, 2024	BUY	N/A	18,730 Added 72.98%	44,395 $2.08 Billion
Q4 2012 Jan 17, 2024	BUY	N/A	1,890 Added 7.95%	25,665 $1.12 Billion
Q3 2012 Jan 17, 2024	BUY	N/A	1,300 Added 5.78%	23,775 $1.1 Billion
Q2 2012 Jan 17, 2024	BUY	N/A	3,560 Added 18.82%	22,475 $1.02 Billion
Q1 2012 Jan 17, 2024	BUY	N/A	18,915 New	18,915 $849 Million
Q1 2009 Jan 17, 2024	SELL	N/A	-214,184 Closed	0 $0
Q4 2008 Jan 17, 2024	SELL	N/A	-3,261 Reduced 1.5%	214,184 $7.98 Billion
Q3 2008 Jan 17, 2024	BUY	N/A	5,737 Added 2.71%	217,445 $9.45 Billion
Q2 2008 Jan 17, 2024	BUY	N/A	20,620 Added 10.79%	211,708 $9.36 Billion
Q1 2008 Jan 17, 2024	BUY	N/A	25,720 Added 15.55%	191,088 $8.11 Billion
Q4 2007 Jan 17, 2024	BUY	N/A	10,429 Added 6.73%	165,368 $8.33 Billion
Q3 2007 Jan 17, 2024	BUY	N/A	21,985 Added 16.54%	154,939 $8.24 Billion
Q2 2007 Jan 17, 2024	BUY	N/A	12,022 Added 9.94%	132,954 $6.96 Billion
Q1 2007 Jan 17, 2024	BUY	N/A	20,039 Added 19.86%	120,932 $6.68 Billion
Q4 2006 Jan 17, 2024	BUY	N/A	100,893	100,893 $5.32 Billion

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.

Account